A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects
Clinical trial NCT01122368 · COMPLETED
Trial details
- NCT number
- NCT01122368
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-13
- Primary completion
- 2011-12-15
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.